drugset / Trial / NCT06744062

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 in Healthy Volunteers Fed Conditions

NCT06744062 ↗

Phase 1 Completed 48 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this clinical trial is to evaluate the pharmacokinetics and the safety after administration of BR1015 and co-administration of BR1015-1 and BR1015-2 in healthy volunteers under fed conditions

Timeline

Start
2025-01-05
Primary completion
2025-03-19
Completion
2025-03-19

Drugs

EvaluationDrugModalityDoseRoute
Subject BR1015 Unknown — —
Comparator BR1015-1 Unknown — —
Comparator BR1015-2 Unknown — —